• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Key genes and regulatory networks for diabetic retinopathy based on hypoxia-related genes: a bioinformatics analysis.基于缺氧相关基因的糖尿病视网膜病变关键基因及调控网络:一项生物信息学分析
Int J Ophthalmol. 2024 Aug 18;17(8):1411-1417. doi: 10.18240/ijo.2024.08.04. eCollection 2024.
2
Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.运用生物信息学分析鉴定 C1QB、ITGAM 和 ITGB2 为糖尿病肾病的潜在诊断候选基因。
PeerJ. 2023 May 25;11:e15437. doi: 10.7717/peerj.15437. eCollection 2023.
3
Bioinformatic Identification of the Pyroptosis-Related Transcription Factor-MicroRNA-Target Gene Regulatory Network in Angiotensin II-Induced Cardiac Remodeling and Validation of Key Components.血管紧张素II诱导的心脏重塑中焦亡相关转录因子-微小RNA-靶基因调控网络的生物信息学鉴定及关键成分验证
Front Biosci (Landmark Ed). 2023 Nov 23;28(11):293. doi: 10.31083/j.fbl2811293.
4
A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.通过综合分析鉴定出一种在非小细胞肺癌中具有强大预测能力的新型缺氧相关基因特征。
Int J Genomics. 2022 May 19;2022:8594658. doi: 10.1155/2022/8594658. eCollection 2022.
5
Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.绒毛膜癌相关微小RNA-转录因子-靶基因调控网络的生物信息学分析及关键微小RNA的验证
Onco Targets Ther. 2021 Jun 29;14:3903-3919. doi: 10.2147/OTT.S311291. eCollection 2021.
6
Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy.糖尿病性视网膜病变中细胞焦亡诱导炎症候选基因的分子研究。
Front Endocrinol (Lausanne). 2022 Jul 25;13:918605. doi: 10.3389/fendo.2022.918605. eCollection 2022.
7
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.通过通路富集分析和枢纽基因- microRNA网络揭示多囊卵巢综合征(PCOS)的关键生物标志物和治疗药物
Iran J Pharm Res. 2023 Nov 20;22(1):e139985. doi: 10.5812/ijpr-139985. eCollection 2023 Jan-Dec.
8
Identification of key genes and immune infiltration in osteoarthritis through analysis of zinc metabolism-related genes.通过分析锌代谢相关基因鉴定骨关节炎的关键基因和免疫浸润。
BMC Musculoskelet Disord. 2024 Mar 21;25(1):227. doi: 10.1186/s12891-024-07347-8.
9
Identification of Oxidative Stress-Related Biomarkers in Diabetic Kidney Disease.糖尿病肾病中氧化应激相关生物标志物的鉴定
Evid Based Complement Alternat Med. 2022 Dec 31;2022:1067504. doi: 10.1155/2022/1067504. eCollection 2022.
10
Identification of hub genes and transcription factor-miRNA-mRNA pathways in mice and human renal ischemia-reperfusion injury.小鼠和人类肾脏缺血再灌注损伤中枢纽基因及转录因子- microRNA - mRNA通路的鉴定
PeerJ. 2021 Oct 26;9:e12375. doi: 10.7717/peerj.12375. eCollection 2021.

引用本文的文献

1
Molecular Imprints of Clinical Comorbidities in Hypothalamic Extracellular Vesicles at the Onset of Obesity.肥胖症发病时下丘脑细胞外囊泡中临床合并症的分子印记
ACS Omega. 2025 May 29;10(22):23563-23581. doi: 10.1021/acsomega.5c02274. eCollection 2025 Jun 10.

本文引用的文献

1
Advances in targeted retinal photocoagulation in the treatment of diabetic retinopathy.糖尿病视网膜病变治疗中靶向视网膜光凝术的进展。
Front Endocrinol (Lausanne). 2023 Mar 2;14:1108394. doi: 10.3389/fendo.2023.1108394. eCollection 2023.
2
Diabetic retinopathy: Looking forward to 2030.糖尿病视网膜病变:展望 2030 年。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1077669. doi: 10.3389/fendo.2022.1077669. eCollection 2022.
3
Amino Acids Metabolism in Retinopathy: From Clinical and Basic Research Perspective.视网膜病变中的氨基酸代谢:从临床和基础研究角度看
Metabolites. 2022 Dec 9;12(12):1244. doi: 10.3390/metabo12121244.
4
Role of hypoxia on microRNA-dependant regulation of HGFA - HGF - c-Met signalling pathway in human progenitor and mature endothelial cells.缺氧对人祖代和成熟内皮细胞中微小 RNA 依赖调控 HGFA-HGF-c-Met 信号通路的作用。
Int J Biochem Cell Biol. 2022 Nov;152:106310. doi: 10.1016/j.biocel.2022.106310. Epub 2022 Sep 28.
5
Molecules related to diabetic retinopathy in the vitreous and involved pathways.玻璃体内与糖尿病视网膜病变相关的分子及涉及的通路。
Int J Ophthalmol. 2022 Jul 18;15(7):1180-1189. doi: 10.18240/ijo.2022.07.20. eCollection 2022.
6
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy.用于治疗糖尿病性视网膜病变中视网膜新生血管的 VEGF 靶向药物。
Ann Med. 2022 Dec;54(1):1089-1111. doi: 10.1080/07853890.2022.2064541.
7
Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.开发和验证一种新型的与脂质代谢相关的基因预后标志物,并为膀胱癌患者找到候选药物。
Lipids Health Dis. 2021 Oct 27;20(1):146. doi: 10.1186/s12944-021-01554-1.
8
Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma.缺氧和免疫相关的胰腺导管腺癌预后标志物的建立和验证。
Front Immunol. 2021 Oct 6;12:728062. doi: 10.3389/fimmu.2021.728062. eCollection 2021.
9
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer.肝癌中的缺氧、代谢重编程与耐药性
Cells. 2021 Jul 6;10(7):1715. doi: 10.3390/cells10071715.
10
The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy.缺氧诱导因子 1α-果糖-2,6-二磷酸酶 3 通路在糖尿病视网膜病变中的作用。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2505-2519. doi: 10.1210/clinem/dgab362.

基于缺氧相关基因的糖尿病视网膜病变关键基因及调控网络:一项生物信息学分析

Key genes and regulatory networks for diabetic retinopathy based on hypoxia-related genes: a bioinformatics analysis.

作者信息

Yu Cai-Han, Wu Cai-Xia, Li Dai, Gong Lan-Lan, Lyu Xu-Dong, Yang Jie

机构信息

Department of Ophthalmology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437100, Hubei Province, China.

School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, Hubei Province, 437100, China.

出版信息

Int J Ophthalmol. 2024 Aug 18;17(8):1411-1417. doi: 10.18240/ijo.2024.08.04. eCollection 2024.

DOI:10.18240/ijo.2024.08.04
PMID:39156775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11286444/
Abstract

AIM

To prevent neovascularization in diabetic retinopathy (DR) patients and partially control disease progression.

METHODS

Hypoxia-related differentially expressed genes (DEGs) were identified from the GSE60436 and GSE102485 datasets, followed by gene ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Potential candidate drugs were screened using the CMap database. Subsequently, a protein-protein interaction (PPI) network was constructed to identify hypoxia-related hub genes. A nomogram was generated using the rms R package, and the correlation of hub genes was analyzed using the Hmisc R package. The clinical significance of hub genes was validated by comparing their expression levels between disease and normal groups and constructing receiver operating characteristic curve (ROC) curves. Finally, a hypoxia-related miRNA-transcription factor (TF)-Hub gene network was constructed using the NetworkAnalyst online tool.

RESULTS

Totally 48 hypoxia-related DEGs and screened 10 potential candidate drugs with interaction relationships to upregulated hypoxia-related genes were identified, such as ruxolitinib, meprylcaine, and deferiprone. In addition, 8 hub genes were also identified: glycogen phosphorylase muscle associated (), glyceraldehyde-3-phosphate dehydrogenase spermatogenic (), enolase 3 (), aldolase fructose-bisphosphate C (), phosphoglucomutase 2 (), enolase 2 (), phosphoglycerate mutase 2 (), and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (). Based on hub gene predictions, the miRNA-TF-Hub gene network revealed complex interactions between 163 miRNAs, 77 TFs, and hub genes. The results of ROC showed that the except for , the area under curve (AUC) values of the other 7 hub genes were greater than 0.758, indicating their favorable diagnostic performance.

CONCLUSION

, , , , , , , and are hub genes in DR, and hypoxia-related hub genes exhibited favorable diagnostic performance.

摘要

目的

预防糖尿病视网膜病变(DR)患者的新生血管形成并部分控制疾病进展。

方法

从GSE60436和GSE102485数据集中鉴定缺氧相关差异表达基因(DEG),随后进行基因本体(GO)功能注释和京都基因与基因组百科全书(KEGG)通路富集分析。使用CMap数据库筛选潜在的候选药物。随后,构建蛋白质-蛋白质相互作用(PPI)网络以鉴定缺氧相关的枢纽基因。使用rms R软件包生成列线图,并使用Hmisc R软件包分析枢纽基因的相关性。通过比较疾病组和正常组之间的表达水平并构建受试者工作特征曲线(ROC)来验证枢纽基因的临床意义。最后,使用NetworkAnalyst在线工具构建缺氧相关的miRNA-转录因子(TF)-枢纽基因网络。

结果

共鉴定出48个缺氧相关的DEG,并筛选出10种与上调的缺氧相关基因具有相互作用关系的潜在候选药物,如鲁索替尼、美普卡因和去铁酮。此外,还鉴定出8个枢纽基因:糖原磷酸化酶肌肉相关()、生精甘油醛-3-磷酸脱氢酶()、烯醇化酶3()、果糖二磷酸醛缩酶C()、磷酸葡萄糖变位酶2()、烯醇化酶2()、磷酸甘油酸变位酶2()和6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶3()。基于枢纽基因预测,miRNA-TF-枢纽基因网络揭示了163个miRNA、77个TF和枢纽基因之间的复杂相互作用。ROC结果显示,除了(此处原文缺失具体基因名)外,其他7个枢纽基因的曲线下面积(AUC)值均大于0.758,表明它们具有良好的诊断性能。

结论

(此处原文缺失具体基因名)、(此处原文缺失具体基因名)、(此处原文缺失具体基因名)、(此处原文缺失具体基因名)、(此处原文缺失具体基因名)、(此处原文缺失具体基因名)、(此处原文缺失具体基因名)和(此处原文缺失具体基因名)是DR中的枢纽基因,且缺氧相关的枢纽基因表现出良好的诊断性能。